Uddin M J, Rahman A F, Rahman S, Momenuzzaman N M, Rahman A, Majumder A S, Mohibullah A M, Chowdhury A H, Malik F N, Ahsan S A, Mohsin K, Haq M M, Chowdhury A W, Sohrabuzzaman A M, Rahman M, Chakraborty B, Rahman R, Khan S R, Khan K N, Reza A M, Hussain K S, Rashid M, Choudhury A K, Karmakar K K, Ali Z, Alam N, Rahman Z, Kabir C S, Banik D, Dutta A, Badiuzzaman M, Islam A W, Sium A H, Hossain M D, Ahmed N, Jahan J, Islam M S, Arefin M M, Cader F A, Banerjee S K, Hoque H, Shofiuddin M, Selim A, Das P K, Ahmed M, Dutto B, Alam S, Paul G K, Paul S K, Azam M G
Professor MG Azam, National Institute of Cardiovascular Diseases, Dhaka, Bangladesh; E-mail:
Mymensingh Med J. 2020 Apr;29(2):488-494.
Since the first recorded case of SARS-CoV-2 in Bangladesh on 8th March 2020, COVID-19 has spread widely through different regions of the country, resulting in a necessity to re-evaluate the delivery of cardiovascular services, particularly procedures pertaining to interventional cardiology in resource-limited settings. Given its robust capacity for human-to-human transmission and potential of being a nosocomial source of infection, the disease has specific implications on healthcare systems and health care professionals faced with performing essential cardiac procedures in patients with a suspected or confirmed diagnosis of COVID-19. The limited resources in terms of cardiac catheterization laboratories that can be designated to treat only COVID positive patients are further compounded by the additional challenges of unavailability of widespread rapid testing on-site at tertiary cardiac hospitals in Bangladesh. This document prepared for our nation by the Bangladesh Society of Cardiovascular Interventions (BSCI) is intended to serve as a clinical practice guideline for cardiovascular health care professionals, with a focus on modifying standard practice of care during the COVID-19 pandemic, in order to ensure continuation of adequate and timely treatment of cardiovascular emergencies avoiding hospital-based transmission of SARS-COV-2 among healthcare professionals and the patients. This is an evolving document based on currently available global data and is tailored to healthcare systems in Bangladesh with particular focus on, but not limited to, invasive cardiology facilities (cardiac catheterization, electrophysiology & pacing labs). This guideline is limited to the provision of cardiovascular care, and it is expected that specific targeted pharmaco-therapeutics against SARS-CoV-2 be prescribed as stipulated by the National Guidelines on Clinical Management of Corona virus Disease 2019 (COVID-19) published by the Director General of Health Services, Ministry of Health and Family Welfare of Bangladesh.
自2020年3月8日在孟加拉国首次记录到新型冠状病毒肺炎（SARS-CoV-2）病例以来，新冠肺炎已在该国不同地区广泛传播，这使得有必要重新评估心血管服务的提供情况，尤其是在资源有限的环境中与介入心脏病学相关的程序。鉴于其强大的人际传播能力以及成为医院感染源的可能性，该疾病对医疗系统和面临为疑似或确诊新冠肺炎患者进行基本心脏手术的医护人员具有特殊影响。孟加拉国三级心脏医院现场缺乏广泛的快速检测，这一额外挑战进一步加剧了仅可指定用于治疗新冠肺炎阳性患者的心导管实验室资源有限的问题。这份由孟加拉国心血管介入协会（BSCI）为我国编写的文件旨在作为心血管医护人员的临床实践指南，重点是在新冠肺炎大流行期间修改标准护理实践，以确保继续充分及时地治疗心血管急症，避免SARS-CoV-2在医护人员和患者之间通过医院传播。这是一份基于当前可用全球数据不断演变的文件，是针对孟加拉国的医疗系统量身定制的，特别关注但不限于侵入性心脏病学设施（心导管检查、电生理与起搏实验室）。本指南仅限于提供心血管护理，预计应按照孟加拉国卫生和家庭福利部卫生服务总局发布的《2019年冠状病毒病（COVID-19）临床管理国家指南》的规定，开具针对SARS-CoV-2的特定靶向药物治疗。
